Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) CEO Margaret Tooth sold 491 shares of the company's stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $31.84, for a total value of $15,633.44. Following the completion of the transaction, the chief executive officer owned 186,952 shares in the company, valued at approximately $5,952,551.68. The trade was a 0.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Margaret Tooth also recently made the following trade(s):
- On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The shares were sold at an average price of $29.05, for a total value of $28,410.90.
Trupanion Stock Performance
NASDAQ:TRUP traded down $1.65 during trading hours on Wednesday, reaching $30.19. The stock had a trading volume of 678,107 shares, compared to its average volume of 439,698. The stock has a market cap of $1.32 billion, a P/E ratio of 56.96, a price-to-earnings-growth ratio of 2.15 and a beta of 1.39. The stock has a 50 day simple moving average of $26.63 and a 200 day simple moving average of $26.02. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $46.98.
Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The company had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. During the same quarter in the prior year, the company earned $0.22 EPS. The firm's quarterly revenue was up 11.1% compared to the same quarter last year. On average, research analysts forecast that Trupanion, Inc. will post 0.63 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the company. BlackRock Inc. bought a new position in shares of Trupanion in the second quarter worth $134,774,000. Polar Capital Holdings Plc grew its position in Trupanion by 13.5% during the fourth quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider's stock worth $55,121,000 after buying an additional 175,000 shares in the last quarter. State Street Corp grew its position in Trupanion by 2.2% during the fourth quarter. State Street Corp now owns 1,290,987 shares of the financial services provider's stock worth $48,244,000 after buying an additional 27,385 shares in the last quarter. Marshall Wace LLP increased its stake in Trupanion by 4.5% in the 4th quarter. Marshall Wace LLP now owns 1,267,262 shares of the financial services provider's stock worth $47,358,000 after acquiring an additional 55,111 shares during the last quarter. Finally, California State Teachers Retirement System increased its stake in Trupanion by 2,314.7% in the 2nd quarter. California State Teachers Retirement System now owns 1,166,023 shares of the financial services provider's stock worth $28,882,000 after acquiring an additional 1,117,735 shares during the last quarter.
Analysts Set New Price Targets
Several analysts have recently issued reports on TRUP shares. Zacks Research lowered shares of Trupanion from a "strong-buy" rating to a "hold" rating in a research report on Monday. Piper Sandler lowered shares of Trupanion from an "overweight" rating to a "neutral" rating and reduced their price objective for the company from $45.00 to $32.00 in a research note on Wednesday. Stifel Nicolaus boosted their target price on shares of Trupanion from $28.00 to $29.00 and gave the company a "hold" rating in a report on Thursday, August 20th. Atlantic Securities set a $42.00 target price on Trupanion in a research report on Wednesday, July 15th. Finally, Weiss Ratings raised Trupanion from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, August 12th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $39.20.
Read Our Latest Report on Trupanion
About Trupanion
(
Get Free Report)
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.